Navigation Links
MicroRNA controls expression of oncogenes
Date:6/9/2008

A new study demonstrates that microRNAs can modulate the expression of well known tumor-specific oncogenic translocation proteins and may play a significant role in some human cancers. The research, published by Cell Press in the June issue of the journal Cancer Cell, is likely to lead to new strategies for treating some specific lymphomas and leukemias.

MicroRNAs (miRNAs) are small noncoding pieces of RNA that can modulate the expression of specific target genes. Recent studies have suggested that increases or decreases in miRNA expression may be linked with regulation of oncogenes or tumor suppressors and are therefore likely to play an important role in human cancers.

Dr. Marcos Malumbres from the Spanish National Cancer Research Center (CNIO) in Madrid, Spain and colleagues identified a miRNA-rich chromosomal region in mice that is frequently lost in T cell malignancies. This particular region encodes about 12% of all genomic miRNAs. The researchers used miRNA expression profiling to reveal that one particular miRNA, miR-203, is silenced by both genetic and epigenetic mechanisms in several mouse and human blood cell malignancies, including chronic myelogenous leukemias and some acute lymphoblastic leukemias.

The researchers went on to show that transcriptional silencing of miR-203 lead to upregulation of the oncogene ABL1 and the BCR-ABL1 oncogenic fusion protein in various mouse and human hematopoietic malignancies. Further, restoration of miR-203 resulted in a subsequent reduction of ABL1 and BCR-ABL1 and in decreased proliferation of tumor cells.

"Our results suggest that miR-203 functions as a tumor suppressor and re-expression of this microRNA might have therapeutic benefits in specific hematopoietic malignancies, including some acute or chronic leukemias," concludes Dr. Malumbres. "This may be particularly beneficial for patients who are resistant to small molecule kinase inhibitors like Gleevec as resistant isoforms of ABL and BCR-ABL should contain the target site for miR-203 and are likely to respond to restored miR-203 function."


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related medicine news :

1. MicroRNAs appear essential for retinal health
2. MicroRNAs, EMT and cancer progression
3. Replacing absent microRNAs could make tumors less invasive, more treatable
4. Single microRNA fine-tunes innate immune response
5. MicroRNAs May Predict Colon Cancer Prognosis
6. 2 microRNAs promote spread of tumor cells
7. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
8. Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification
9. MicroRNAs may be key to HIVs ability to hide, evade drugs, Jefferson scientists find
10. Monkey Controls Robotic Arm With Brain
11. Stem Cell Marker Controls Pair of Key Cancer Pathways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Super-Sod will ... and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home ... Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture from ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, ... Center on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar ... in our community. We are thrilled to participate in this event because we believe ...
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a leading ... spend management, today announced that Keppel Corporation has selected Apptricity Travel and Expense ... , “We are excited to announce the partnership between Keppel and Apptricity for ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal ... therapies for both rare and common malignancies, today ... B financing. The company intends to use the ... and TK216, and to advance preclinical development of ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody ...
(Date:2/22/2017)... R.I. , Feb. 22, 2017  CVS Pharmacy ... the removal of partially hydrogenated oils (PHO), the primary ... all its exclusive store brands food products. The retailer ... which are free from artificial trans fats. This comes a ... Drug Administration,s deadline of June 2018 for processed foods ...
(Date:2/22/2017)... , Colombie-Britannique, February 22, 2017 Des scanners sur ... vente en Europe , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , ... Vancouver , au Canada , a annoncé ... des Scanners Échographiques Sans fil Clarius C3 et L7, destinés à être ...
Breaking Medicine Technology: